100 related articles for article (PubMed ID: 30592774)
1. Design, synthesis, and biological evaluation of phenylcyclopropylamine-entinostat conjugates that selectively target cancer cells.
Ota Y; Itoh Y; Takada Y; Yamashita Y; Hu C; Horinaka M; Sowa Y; Masuda M; Sakai T; Suzuki T
Bioorg Med Chem; 2024 Feb; 100():117632. PubMed ID: 38340642
[TBL] [Abstract][Full Text] [Related]
2. Structural optimization of a lysine demethylase 5 inhibitor for improvement of its cellular activity.
Terao M; Yamashita Y; Takada Y; Itoh Y; Suzuki T
Bioorg Med Chem; 2024 Jan; 98():117579. PubMed ID: 38168630
[TBL] [Abstract][Full Text] [Related]
3. Ophiobolin A derivatives with enhanced activities under tumor-relevant acidic conditions.
Maslivetc VA; Nabiul Hasan M; Boari A; Zejnelovski A; Evidente A; Sun D; Kornienko A
Bioorg Med Chem Lett; 2024 Jun; ():129863. PubMed ID: 38942129
[TBL] [Abstract][Full Text] [Related]
4. Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma.
Lee C; Rudneva VA; Erkek S; Zapatka M; Chau LQ; Tacheva-Grigorova SK; Garancher A; Rusert JM; Aksoy O; Lea R; Mohammad HP; Wang J; Weiss WA; Grimes HL; Pfister SM; Northcott PA; Wechsler-Reya RJ
Nat Commun; 2019 Jan; 10(1):332. PubMed ID: 30659187
[TBL] [Abstract][Full Text] [Related]
5. The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma.
Bhaskaran V; Nowicki MO; Idriss M; Jimenez MA; Lugli G; Hayes JL; Mahmoud AB; Zane RE; Passaro C; Ligon KL; Haas-Kogan D; Bronisz A; Godlewski J; Lawler SE; Chiocca EA; Peruzzi P
Nat Commun; 2019 Jan; 10(1):442. PubMed ID: 30683859
[TBL] [Abstract][Full Text] [Related]
6. HOXD8/DIAPH2-AS1 epigenetically regulates PAX3 and impairs HTR-8/SVneo cell function under hypoxia.
Feng Y; Wang J; He Y; Zhang H; Jiang M; Cao D; Wang A
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30626726
[TBL] [Abstract][Full Text] [Related]
7. Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma.
Bais MV
J Dent Res; 2019 Mar; 98(3):268-276. PubMed ID: 30615537
[TBL] [Abstract][Full Text] [Related]
8. Identification of selective and reversible LSD1 inhibitors with anti-metastasis activity by high-throughput docking.
Li L; Li R; Wang Y
Bioorg Med Chem Lett; 2019 Feb; 29(4):544-548. PubMed ID: 30611617
[TBL] [Abstract][Full Text] [Related]
9. Discovery of vanadium complexes bearing tridentate schiff base ligands as novel LSD1 inhibitors.
Lu LP; Liu JH; Cen SH; Jiang YL; Hu GQ
Bioorg Med Chem Lett; 2019 Feb; 29(4):681-683. PubMed ID: 30611616
[TBL] [Abstract][Full Text] [Related]
10. Histone demethylases regulate adipocyte thermogenesis.
Inagaki T
Diabetol Int; 2018 Oct; 9(4):215-223. PubMed ID: 30603371
[TBL] [Abstract][Full Text] [Related]
11. Natural products as LSD1 inhibitors for cancer therapy.
Fang Y; Yang C; Yu Z; Li X; Mu Q; Liao G; Yu B
Acta Pharm Sin B; 2020 Jun; 11(3):621-31. PubMed ID: 32837872
[TBL] [Abstract][Full Text] [Related]
12. LSD1/KDM1A inhibitors in clinical trials: advances and prospects.
Fang Y; Liao G; Yu B
J Hematol Oncol; 2019 Dec; 12(1):129. PubMed ID: 31801559
[TBL] [Abstract][Full Text] [Related]
13. 4,5-Dimethoxycanthin-6-one is a novel LSD1 inhibitor that inhibits proliferation of glioblastoma cells and induces apoptosis and pyroptosis.
Li W; Huang BS; Xiong YY; Yang LJ; Wu LX
Cancer Cell Int; 2022 Jan; 22(1):32. PubMed ID: 35042538
[TBL] [Abstract][Full Text] [Related]
14. Nitroreductase-Mediated Release of Inhibitors of Lysine-Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia Cells.
Herrlinger EM; Hau M; Redhaber DM; Greve G; Willmann D; Steimle S; Müller M; Lübbert M; Miething CC; Schüle R; Jung M
Chembiochem; 2020 Aug; 21(16):2329-2347. PubMed ID: 32227662
[TBL] [Abstract][Full Text] [Related]
15. Data-Driven Identification of Hydrogen Sulfide Scavengers.
Yang CT; Wang Y; Marutani E; Ida T; Ni X; Xu S; Chen W; Zhang H; Akaike T; Ichinose F; Xian M
Angew Chem Int Ed Engl; 2019 Aug; 58(32):10898-10902. PubMed ID: 31194894
[TBL] [Abstract][Full Text] [Related]
16. Novel dual-action prodrug triggers apoptosis in glioblastoma cells by releasing a glutathione quencher and lysine-specific histone demethylase 1A inhibitor.
Engel M; Gee YS; Cross D; Maccarone A; Heng B; Hulme A; Smith G; Guillemin GJ; Stringer BW; Hyland CJT; Ooi L
J Neurochem; 2019 May; 149(4):535-550. PubMed ID: 30592774
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.
Singh MM; Manton CA; Bhat KP; Tsai WW; Aldape K; Barton MC; Chandra J
Neuro Oncol; 2011 Aug; 13(8):894-903. PubMed ID: 21653597
[TBL] [Abstract][Full Text] [Related]
18. Combination LSD1 and HOTAIR-EZH2 inhibition disrupts cell cycle processes and induces apoptosis in glioblastoma cells.
Zhao J; Jin W; Yi K; Wang Q; Zhou J; Tan Y; Xu C; Xiao M; Hong B; Xu F; Zhang K; Kang C
Pharmacol Res; 2021 Sep; 171():105764. PubMed ID: 34246782
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
